Literature DB >> 14959839

Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays.

John E Butler1.   

Abstract

Most modern immunoassays involve the use of synthetic solid phases to immobilize one of the reactants, often by simple adsorption. These solid-phase immunoassays (SPIs) involve ligand-receptor interactions that occur within a reaction volume close to the solution/solid-phase interface. As a consequence, the immunochemistry/biochemistry of these ligand-receptor interactions differ from their counterparts in solution. Nevertheless, mass law equations can be derived for measuring the antigen capture of solid-phase antibodies, for determining the affinity of solid phases for protein adsorption, and for estimating antibody affinity. Many proteins adsorbed on polystyrene or silicone suffer adsorption-induced conformational changes (ACC) and are partially or largely denatured. Alternative methods for immobilizing proteins and virus, while preserving antigenicity, may yield only a modest increase in functional reactant concentration. Peptides and small recombinant proteins appear to benefit especially from nonadsorptive immobilization. Not all solid phases commonly used in SPIs have the same properties, the same capacity for reactant immobilization, cause the same level of denaturation, or experience the same level of nonspecific binding. Empiricism, adherence to a few practical rules of thumb, and avoidance of certain "old wives tales" can be valuable in the successful development of SPIs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14959839     DOI: 10.1385/1-59259-679-7:333

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  7 in total

1.  The use of amphipols as universal molecular adapters to immobilize membrane proteins onto solid supports.

Authors:  Delphine Charvolin; Jean-Baptiste Perez; Florent Rouvière; Fabrice Giusti; Paola Bazzacco; Alaa Abdine; Fabrice Rappaport; Karen L Martinez; Jean-Luc Popot
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-30       Impact factor: 11.205

2.  Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease.

Authors:  Anton V Bryksin; Henry P Godfrey; Carol A Carbonaro; Gary P Wormser; Maria E Aguero-Rosenfeld; Felipe C Cabello
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 3.  The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis.

Authors:  Franz X Heinz; Karin Stiasny
Journal:  Microbiol Mol Biol Rev       Date:  2017-02-08       Impact factor: 11.056

4.  Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites.

Authors:  Karin Stiasny; Stefan Kiermayr; Heidemarie Holzmann; Franz X Heinz
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids.

Authors:  Oscar B Torres; Alexander J Duval; Agnieszka Sulima; Joshua F G Antoline; Arthur E Jacobson; Kenner C Rice; Carl R Alving; Gary R Matyas
Journal:  Anal Bioanal Chem       Date:  2018-04-19       Impact factor: 4.142

6.  Development of a highly sensitive enzyme-linked immunosorbent assay (ELISA) through use of poly-protein G-expressing cell-based microplates.

Authors:  Yi-Jou Chen; Michael Chen; Yuan-Chin Hsieh; Yu-Cheng Su; Chang-Hung Wang; Chiu-Min Cheng; An-Pei Kao; Kai-Hung Wang; Jing-Jy Cheng; Kuo-Hsiang Chuang
Journal:  Sci Rep       Date:  2018-12-14       Impact factor: 4.379

7.  Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation.

Authors:  Laura J Sherwood; Andrew Hayhurst
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.